Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Aphria

MedMen Enterprises Inc.

SNDL Inc.

Tilray Brands

Should You Buy These Hot Cannabis Stocks Before It's Too Late?

Aurora Cannabis

Cannabis company stocks are getting a boost after another U.S. state passed legalization legislation.

Why Aphria, Canopy Growth, and Aurora Cannabis Stocks Jumped Today

End-to-end value cannabis stocks operating in Canada are flying high, but a retracement to near fair value is imminent. The cannabis industry is changing due to vertical integration being scrapped and an influx of competitors.

Canadian End-To-End Value Cannabis Stocks Present Opportunities For Short Sellers

Green Thumb Industries Inc.

Top marijuana stocks rose as Virginia lawmakers on Saturday approved legislation that would legalize recreational use of cannabis by 2024. The post Marijuana Stocks Surge As First Southern State OKs Recreational Use appeared first on Investor's Business Daily.

Marijuana Stocks Surge As First Southern State OKs Recreational Use

With the discount in CGC stock, it may be time to advantage over due to encouraging consumer developments, but you should also be aware of the economic risks. The post Canopy Growth Stock Can Resist Any Cannabis Headwinds appeared first on InvestorPlace.

Canopy Growth Stock Can Resist Any Cannabis Headwinds

The COVID-19 pandemic accelerated demand for tools to cope with stress management and anxiety, Canopy Growth Corp (NASDAQ:CGC) President and Chief Product Officer Rade Kovacevic said Friday during Benzinga's Cannabis Capital Conference.  Cannabis And Stress Management: It goes without saying that rising anxiety is a trend that was seen worldwide, and this created new opportunities for both the cannabis industry as a whole and Canopy Growth, Kovacevic said during the virtual Benzinga conference.

Canopy Growth's Chief Product Officer On How COVID-19 Accelerated Cannabis Demand

Canopy Growth is trading at levels not seen in 20 months. News from off the beaten path tells me CGC stock will keep moving higher.

Canopy Growth's Canadian Business Looks Ready to Roll

Cronos Group

The cannabis sector has yet to completely shed its reputation of being part of the "wild, wild west," but much has changed, T3 Ventures President Tahira Rehmatullah said Thursday during Benzinga's virtual Cannabis Capital Conference.  Cannabis operators with plenty of experience have likely at some point entered into a deal where there was no model or the depth that was needed, Rehmatullah said.

Why The Stigma Around Cannabis Investments Is 'Gone'

The company isn't the best play on eventual U.S. decriminalization/legalization, according to a Jefferies prognosticator.

Canopy Growth Is Poised to Fall by 35%, Says Analyst

ARK Innovation ETF

Plug Power

Picking a bottom is tough, but price charts and options strategies are making that decision easier for these three downtrodden stocks to buy. The post 3 Downtrodden Stocks to Buy Right Now appeared first on InvestorPlace.

3 Downtrodden Stocks to Buy Right Now

GameStop

HEXO Corp

The bubble pop is moving quickly from sector to sector as marijuana stocks took center stage in one of the biggest and quickest to rise and fall recently. The post 7 Marijuana Stocks That Could Still Go Down in Flames appeared first on InvestorPlace.

7 Marijuana Stocks That Could Still Go Down in Flames

The AdvisorShares Pure US Cannabis ETF has surpassed $1 billion in assets under management, according to a company statement released Tuesday. The ETF, which trades under the ticker MSOS, launched on September 2, 2020 and has grown from $2.5 million in assets to now $1 billion in just six months. The fund has returned 110% since its inception and 37% in 2021 alone. The AdvisorShares ETF was the first US exchange traded fund to focus solely on American cannabis companies and multi-state operations (MSOs), or companies directly involved in the legal production and distribution of cannabis.  The fund's inflows are a sign of growing investor interest in the cannabis space amid speculation that the Biden administration will keep its campaign promises and decriminalize marijuana. Some Democrats in Congress have pushed even further, advocating for the full legalization of cannabis in the US.

The first US cannabis ETF surpassed $1 billion in AUM in its first 6 months of trading

Curaleaf Holdings, Inc.

CRON stock stands to gain from state-level cannabis legalization as well as from speculation around federal legalization. The post Cronos Group and Other Cannabis Stocks Could See Higher Highs appeared first on InvestorPlace.

Cronos Group and Other Cannabis Stocks Could See Higher Highs

Canopy Growth holds conditional ownership of approximately 20% in TerrAscend SMITHS FALLS, ON, Feb. 23, 2021 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth") (TSX: WEED) (NASDAQ: CGC) announces that it has closed the previously announced plan of arrangement under the Business...

Canopy Growth Announces Closing of Plan of Arrangement Involving RIV Capital

Canopy Growth bled money again in the last quarter as Multi-State Operators posted profits, suggesting the latter is a better investment. The post Sell Canopy Growth Stock Right Now, and Buy It Back Cheaper in August appeared first on InvestorPlace.

Sell Canopy Growth Stock Right Now, and Buy It Back Cheaper in August

The ETFMG Alternative Harvest ETF (NYSE: MJ) traded lower on Monday as investors continued to take profits on the post-election run-up in cannabis stocks. This week is a big week in the cannabis space with several potential catalysts of note ahead.

4 Things Cannabis Investors Should Watch This Week

CGC stock and other cannabis names are on the rise with Democrats taking Congress and the White House. But you'll need to be patient.

Your Patience Will Pay Off With Canopy Growth Stock

Marijuana stocks have outpaced the broader market so far this year and the gains could continue as retail investors pile in. The post 4 Marijuana Stocks That Are Surging appeared first on InvestorPlace.

4 Marijuana Stocks That Are Surging

They're slowly becoming the rock-solid businesses he favors.

2 Hot Marijuana Stocks Even Warren Buffett Might Want to Buy in 2021

This isn't even close to a difficult decision.

Forget Sundial Growers, Canopy Growth Is a Better Marijuana Stock

The company is getting out of the venture capital business.

Why Canopy Growth Popped 5.4% Higher Today

The ETFMG Alternative Harvest ETF (NYSE: MJ) rebounded by 3.1% on Friday to around $25, but the find is still way off its February high of near $35. On Friday, DataTrek Research co-founder Jessica Rabe discussed what drove the early 2021 cannabis stock rally and three reasons why it has run out of steam in the past two weeks.

3 Reasons Cannabis Stocks May Be Headed Lower

Arena Pharmaceuticals

GW Pharmaceuticals

New Age Beverages

cbdMD Inc

Welcome back to our weekly series, Sc haeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will continue to develop in the 2021.

9 Red-Hot Cannabis Stocks Blazing This Week

Amplify Seymour Cannabis ETF

Jazz Pharmaceuticals

Amplify Alternative Harvest ETF

Global X Cannabis ETF

AXS Cannabis ETF

Cambria Cannabis ETF

Village Farms International

AdvisorShares Pure Cannabis ETF 

CNBC's cannabis expert Tim Seymour discusses the outlook for the industry.

Should You Invest in Marijuana Stocks & ETFs Now?

TORONTO, Feb. 18, 2021 /PRNewswire/ - Canopy Rivers Inc. ("Rivers" or the "Company") today announced that the Ontario Superior Court of Justice (Commercial List) has approved the previously announced plan of arrangement (the "Arrangement") involving Canopy Growth Corporation ("Canopy...

Rivers Obtains Court Approval of the Arrangement with Canopy Growth

News for Canopy Growth Stock (CGC)